Development of an ex-vivo transmission blocking assay for clinical isolates of matured Plasmodium falciparum gametocytes through membrane feeding assays African Academy of Science (AAS), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Dinkorma Ouologuem | Africa, Central, Africa, Eastern, Africa, Southern, Mali
Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine African Malaria Network Trust (AMANET), Tanzania, University of Bamako, Mali | Mahamadou S. Sissoko | Africa, Western, Mali
Understanding the biology of Plasmodium vivax and Plasmodium ovale for the development of a field-based anti-hypnozoite drug screening model (HypnoBio) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Laurent Dembele | Ethiopia, Mali
School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali National Center for Scientific and Technological Research (CNRST), Mali, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Ogobara Doumbo, Mahamadou S. Sissoko | Mali
Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye…
Malaria in pregnant is a public health problem in sub Saharan countries where 11 million pregnancies are exposed to malaria infection. Plasmodium falciparum in pregnant can cause adverse maternal health and poor birth outcomes. Artemisin-based Combination Therapy (ACT) used in treatment of uncomplicated Plasmodium falciparum malaria in pregnant women has the efficacy in Africa. The…
Efficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women (PYRAPREG) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Kassoum Kayentao | Dem. Rep. Congo, Mozambique, Burkina Faso, Gambia, Mali